The application of machine learning for treatment selection of unruptured brain arteriovenous malformations: A secondary analysis of the ARUBA trial data.

Journal: Clinical neurology and neurosurgery
Published Date:

Abstract

OBJECTIVE: To build a supervised machine learning (ML) model that selects the best first-line treatment strategy for unruptured bAVMs.

Authors

  • Tejas Venkataram
    Department of Neurosurgery, St. John's Medical College Hospital, Bengaluru, India.
  • Shreyas Kashyap
    Independent Researcher, Bengaluru, India.
  • Mandara M Harikar
    Clinical Trials Programme, Usher Institute of Molecular, Genetic, and Population Health Sciences, The University of Edinburgh, Edinburgh, UK.
  • Francesco Inserra
    Department of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Catania, Italy.
  • Fabio Barone
    Department of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Catania, Italy.
  • Mario Travali
    Department of Diagnostic and Interventional Neuroradiology, Azienda Ospedaliera Cannizzaro, Catania, Italy.
  • Valeriox Da Ros
    Diagnostic Imaging Unit, Department of Biomedicine and Prevention, 9318 University of Rome Tor Vergata, Italy.
  • Giuseppe E Umana
    Department of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, Catania, Italy.
  • Oluseye A Ogunbayo
    Edinburgh Surgery Online, Clinical Science Teaching Organisation, Clinical Surgery, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.
  • Benjamin Aribisala
    Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK; Lothian Birth Cohort studies, Department of Psychology, University of Edinburgh, Edinburgh, UK; Department of Computer Science, Lagos State University, Nigeria. Electronic address: Benjamin.Aribisala@ed.ac.uk.